Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 10, 2025 - Biocon announced the FDA approval of Jobevne (bevacizumab-nwgd), biosimilar to Genentech’s Avastin® (bevacizumab).
Download PDF
Return to publications
